Literature DB >> 29030422

Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.

Gregoire Boulouis1, Andrea Morotti2, Marco Pasi3,4, Joshua N Goldstein3,4,5, M Edip Gurol3,4, Andreas Charidimou3,4.   

Abstract

INTRODUCTION: The characteristics and natural history of acute non-vitamin K antagonists oral anticoagulants (NOAC)-associated intracerebral haemorrhage (ICH) are largely unknown. We performed a comprehensive systematic review and meta-analysis to compare baseline ICH volume, haematoma expansion and clinical outcomes between NOAC-ICH versus vitamin K antagonists-ICH (VKA-ICH).
METHODS: We searched PubMed and conference abstracts for observational studies comparing baseline characteristics and outcomes in patients with NOAC-ICH versus VKA-ICH using an appropriate keyword/MeSH term search strategy. Data were extracted following PRISMA and MOOSE guidelines. The main outcome measures were mortality and unfavourable functional outcome (modified Rankin Score: 4-6) at discharge and at 3 months, as well as ICH volumes and haematoma expansion rates in the two groups. Random-effects models with DerSimonian-Laird weights were used for pooled estimates calculation.
RESULTS: Twelve studies including 393 NOAC-ICH and 3482 VKA-ICH were pooled in meta-analysis. There was no difference in mean ICH-volume between the two groups (standard mean difference: -0.24; 95% CI -0.52 to 0.04, p=0.093). The rates of haematoma expansion were comparable in NOAC-ICH versus VKA-ICH (OR: 0.76; 95% CI 0.49 to 1.19, p=0.236). We did not find any difference between patients with NOAC-ICH versus VKA-ICH in all-cause mortality at discharge (OR: 0.66; 95% CI 0.42 to 1.05, p=0.077) and unfavourable functional outcome at discharge (OR: 0.77; 95% CI 0.41 to 1.44, p=0.413). The 3-month outcome was also comparable between the two ICH groups. Moderate-to-substantial statistical heterogeneity was noted.
CONCLUSION: Our results confirm that ICH volume, haematoma expansion, mortality and functional outcome appear to be similar for NOAC-ICH versus VKA-ICH. Large prospective cohorts and updated meta-analyses are needed to provide more precise estimates. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  acute therapy; anticoagulation; hematoma expansion; intracerebral haemorrhage; meta-analysis; outcome; stroke

Mesh:

Substances:

Year:  2017        PMID: 29030422     DOI: 10.1136/jnnp-2017-316631

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

Review 1.  Management of patients with stroke treated with direct oral anticoagulants.

Authors:  D J Seiffge; A A Polymeris; J Fladt; P A Lyrer; S T Engelter; Gian Marco De Marchis
Journal:  J Neurol       Date:  2018-10-06       Impact factor: 4.849

Review 2.  Impact of Recent Studies for the Treatment of Intracerebral Hemorrhage.

Authors:  Jochen A Sembill; Hagen B Huttner; Joji B Kuramatsu
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-20       Impact factor: 5.081

3.  Trends in incidence of oral anticoagulant-related intracerebral hemorrhage and sales of oral anticoagulants in Capital Region of Denmark 2010-2017.

Authors:  Josefine Grundtvig; Christian Ovesen; Inger Havsteen; Thomas Christensen; David Gaist; Helle K Iversen; Christina Kruuse; Alexander Lilja-Cyron; Karen Ægidius; Sverre Rosenbaum; Per Meden; Jacob Marstrand; Louisa Christensen; Thorsten Steiner; Hanne Christensen
Journal:  Eur Stroke J       Date:  2021-04-07

4.  Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage.

Authors:  Vasileios-Arsenios Lioutas; Nitin Goyal; Aristeidis H Katsanos; Christos Krogias; Ramin Zand; Vijay K Sharma; Panayiotis Varelas; Konark Malhotra; Maurizio Paciaroni; Aboubakar Sharaf; Jason Chang; Theodore Karapanayiotides; Odysseas Kargiotis; Alexandra Pappa; Jeffrey Mai; Abhi Pandhi; Christoph Schroeder; Argyrios Tsantes; Chandan Mehta; Ali Kerro; Ayesha Khan; Panayiotis D Mitsias; Magdy H Selim; Andrei V Alexandrov; Georgios Tsivgoulis
Journal:  Stroke       Date:  2018-10       Impact factor: 7.914

5.  Management of Patients with Acute Subdural Hemorrhage During Treatment with Direct Oral Anticoagulants.

Authors:  Christopher Beynon; Steffen Brenner; Alexander Younsi; Timolaos Rizos; Jan-Oliver Neumann; Johannes Pfaff; Andreas W Unterberg
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

6.  Clinical and Radiological Characteristics of Vitamin K Versus Non-Vitamin K Antagonist Oral Anticoagulation-Related Intracerebral Hemorrhage.

Authors:  Małgorzata M Miller; Jessica Lowe; Muhib Khan; Muhammad U Azeem; Susanne Muehlschlegel; Adalia H Jun-O'Connell; Richard P Goddeau; Majaz Moonis; Danielle Gritters; Brian Silver; Nils Henninger
Journal:  Neurocrit Care       Date:  2019-08       Impact factor: 3.210

7.  Differences in bleeding patterns and outcome after intracerebral hemorrhage due to vascular malformations.

Authors:  Nazife Dinc; Sae-Yeon Won; Nina Brawanski; Michael Eibach; Johanna Quick-Weller; Jürgen Konczalla; Joachim Berkefeld; Volker Seifert; Gerhard Marquardt
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

8.  How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH).

Authors:  Alessandro Prior; Pietro Fiaschi; Corrado Iaccarino; Roberto Stefini; Denise Battaglini; Alberto Balestrino; Pasquale Anania; Enrico Prior; Gianluigi Zona
Journal:  BMC Neurol       Date:  2021-03-03       Impact factor: 2.474

9.  Imaging-Based Outcome Prediction of Acute Intracerebral Hemorrhage.

Authors:  Jawed Nawabi; Helge Kniep; Sarah Elsayed; Constanze Friedrich; Peter Sporns; Thilo Rusche; Maik Böhmer; Andrea Morotti; Frieder Schlunk; Lasse Dührsen; Gabriel Broocks; Gerhard Schön; Fanny Quandt; Götz Thomalla; Jens Fiehler; Uta Hanning
Journal:  Transl Stroke Res       Date:  2021-02-06       Impact factor: 6.829

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.